For: | Huang CT, Liang YJ. Anti-tumor effect of statin on pancreatic adenocarcinoma: From concept to precision medicine. World J Clin Cases 2021; 9(18): 4500-4505 [PMID: 34222418 DOI: 10.12998/wjcc.v9.i18.4500] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i18/4500.htm |
Number | Citing Articles |
1 |
Candace Miyaki, Launa M Lynch. An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer. Cureus 2022; doi: 10.7759/cureus.25496
|
2 |
Yan Ou, Gina Chia-Yi Chu, Ji Lyu, Liyuan Yin, Adrian Lim, Ning Zhai, Xiaojiang Cui, Michael S. Lewis, Mouad Edderkaoui, Stephen J. Pandol, Ruoxiang Wang, Yi Zhang. Overcoming Resistance in Prostate Cancer Therapy Using a DZ-Simvastatin Conjugate. Molecular Pharmaceutics 2024; 21(2): 873 doi: 10.1021/acs.molpharmaceut.3c00993
|
3 |
Christina Grinstead, Thomas George, Bo Han, Saunjoo L. Yoon. Associations of Overall Survival with Geriatric Nutritional Risk Index in Patients with Advanced Pancreatic Cancer. Nutrients 2022; 14(18): 3800 doi: 10.3390/nu14183800
|
4 |
Arunima Maiti, Susmita Mondal, Sounetra Choudhury, Arnab Bandopadhyay, Sanghamitra Mukherjee, Nilabja Sikdar. Oncometabolites in pancreatic cancer: Strategies and its implications. World Journal of Experimental Medicine 2024; 14(4): 96005 doi: 10.5493/wjem.v14.i4.96005
|
5 |
Sneha Tripathi, Ekta Gupta, Sanjeev Galande. Statins as anti‐tumor agents: A paradigm for repurposed drugs. Cancer Reports 2024; 7(5) doi: 10.1002/cnr2.2078
|